NEWS & EVENTS

GenDx Shining at WHX Labs Dubai

update time:2025-02-07     Reading times: 45 +



On February 6, 2025, the Medlab Middle East 2025, which was officially renamed "WHX Labs Dubai" came to an end. As the most influential event in the field of laboratory diagnostic equipment in the Middle East, it attracted more than 800 well-known manufacturers from over 40 countries and regions around the world.

d5df9d6c985a1dda085f6c7892817df5.png

On the world stage, GenDx made its debut at the Dubai World Trade Center. With its remarkable achievement of rapid and accurate nucleic acid testing in just 10 minutes, it became the focus of attention in the ZABEEL Hall.

z.png

At the exhibition, the "10-minute nucleic acid testing solution" of the GE4+ pen-type microfluidics brought a great shock to the visitors and became the star solution of the whole venue. Its mature ERA technology, minimalist engineering design, and the huge advantage of up to 5 CFU/ml LOD met the needs of the vast majority of customers for single-sample testing in different application scenarios.

GD-220+GE4 2024-d.png

GenDx also launched the "20-minute ultra-multiplex testing solution" of the GCP-30 + GENECHIP. With highlights such as "30-item detection in one test, results available in 20 minutes", "fully enclosed after sampling without the need to open the cover", and User customized service, it met the diverse needs of different customers.

GCP-30 2024-d.png


As the owner of the global independent intellectual property ERA technology, GenDx has been committed to the industrialization of molecular POCT, leading the upgrade of the global 10-minute nucleic acid rapid testing technology, continuously promoting the improvement of the global in-vitro diagnostic level and capabilities, and safeguarding medical health. The outstanding achievements of this exhibition not only made the vast number of partners full of confidence in cooperating with Sinocare Gene, but also made Sinocare Gene more determined in its mission. It is committed to the development of rapid, accurate, and convenient testing technologies, enabling gene technology to serve the public.